Vishnevskiĭ A S, Bokhman Ia V, Tsyrlina E V, Bobrov Iu F, Shtofmakher I A
Vopr Onkol. 1989;35(9):1063-7.
Oxyprogesterone capronate (OPC) was administered preoperatively to 46 patients with endometrial tumors and tamoxifen (T) + OPC--to 72 patients. Complex treatment was followed by more pronounced pathomorphosis in tumor. Both schedules inhibited gonadotropin secretion and lowered colpocytoscopic indexes. Dual effect of complex treatment (T + OPC) on the level of cytoplasmic receptors to progesterone was observed. Initially low levels rose while high ones dropped by the end of a 20-day course. Progestin treatment in endometrial carcinoma patients with relatively low estrogen levels should be complemented with tamoxifen to stimulate tumor sensitivity to progestagens.
术前对46例子宫内膜肿瘤患者给予己酸羟孕酮(OPC),对72例患者给予他莫昔芬(T)+OPC。综合治疗后肿瘤出现更明显的病理形态改变。两种方案均抑制促性腺激素分泌并降低阴道细胞学指数。观察到综合治疗(T+OPC)对孕酮细胞质受体水平有双重作用。最初较低的水平升高,而较高的水平在20天疗程结束时下降。对于雌激素水平相对较低的子宫内膜癌患者,孕激素治疗应辅以他莫昔芬以刺激肿瘤对孕激素的敏感性。